JOSÉ ÁNGEL
HERNÁNDEZ RIVAS
Profesor asociado
VU University Medical Center
Ámsterdam, HolandaVU University Medical Center-ko ikertzaileekin lankidetzan egindako argitalpenak (2)
2022
-
B-cell malignancies treated with targeted drugs and SARS-CoV-2 infection: A European Hematology Association Survey (EPICOVIDEHA)
Frontiers in Oncology, Vol. 12
-
Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey
Blood, Vol. 140, Núm. 26, pp. 2773-2787